Does the LENT score risk-stratify patients with malignant pleural mesothelioma? An observational study.
Bertrand CholletJulien GuindeSophie LaroumagneHervé DutauPhilippe AstoulPublished in: Thoracic cancer (2021)
Applied to a homogenous cohort of MPM patients, the LENT score underestimated prognosis and was not useful per se for the management of this disease, as evidenced in the epithelial mesothelioma subgroup of patients in our study.